Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes
about
sameAs
F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profileHeritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.Lack of abuse potential in a highly selective dopamine D3 agonist, PF-592,379, in drug self-administration and drug discrimination in ratsMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens.The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats.The behavioral pharmacology of hallucinogensDesign, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profileRecent advances in the neuropsychopharmacology of serotonergic hallucinogensRotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptorsStereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in ratsDrugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysisTransdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's diseaseDopamine agonists in Parkinson's diseaseHomology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluationConversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out miceParametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats.The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J miceUsing prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsPramipexole effects on startle gating in rats and normal menPhenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in ratsDopamine and pain sensitivity: neither sulpiride nor acute phenylalanine and tyrosine depletion have effects on thermal pain sensations in healthy volunteersExpression and distribution of all dopamine receptor subtypes (D(1)-D(5)) in the mouse lumbar spinal cord: a real-time polymerase chain reaction and non-autoradiographic in situ hybridization study.Reward networks in the brain as captured by connectivity measuresImpulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control studyVentricular bigeminy after subcutaneous administration of apomorphine in a patient with refractory Parkinson's disease: a case reportDopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.Localization and function of dopamine receptors in the subthalamic nucleus of normal and parkinsonian monkeys.The role of beta-arrestin2 in shaping fMRI BOLD responses to dopaminergic stimulationBinding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457.Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitorsCabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor.Drug-induced valvulopathy: an update.In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotypeTargeting the dopamine D3 receptor: an overview of drug design strategies.S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosisApomorphine and Alzheimer Aβ: roles for regulated α cleavage, autophagy, and antioxidation?Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists.Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice
P2860
Q24564964-E5E333FB-D782-4630-97ED-C55360A0A284Q24612495-F5023723-A771-4B00-9551-0A556CE326EEQ24614563-11244C03-9639-4546-8DF0-A6B911D7DD6AQ24620764-0ECD28A6-6715-45E6-A757-FB09B2AE11F5Q24628933-45B73E5A-E180-4E79-BC49-49D658556761Q24645656-2FAEF9FF-27FB-4E37-8CF7-590F556CD10CQ24651049-B1EE83DB-1295-4166-820A-2B487CB5B3FAQ27027381-F454402D-9161-4400-B07E-CAFE58854BB3Q28250152-1B291F32-E93F-47F1-922C-79E0E9741E1AQ28256971-A1403E79-31E4-4A8C-B57E-F2EE6280E043Q28258219-FD11AA87-C9EB-4C71-A347-7D7A57E69EBDQ28266116-51223BBC-762D-4C91-9141-DF8BE736F88AQ28276692-2F6B2645-F2D0-42FA-BB3A-4E000E10817FQ28483632-7A405399-BF2B-48D3-8A6F-D30FD80E6837Q28508917-72BF8803-08F0-44A8-ACA3-378B44A88C08Q30475352-B72F93BB-6350-48A2-92B2-4390E3BCBD65Q30476573-97CFC740-76D9-43D7-A2A9-E14E3AB6FBB3Q30480298-4046CB08-6618-47BC-BDA0-BDF7DB8C09E3Q30484494-8B10ACC9-ADCA-4311-94EE-8A095C36C712Q30486707-45B8DEB1-3D99-4792-BDA4-65B9848116FCQ30487682-AD7918ED-573B-4B88-A814-36919CB6D012Q30581703-94C7C1B2-BFC3-4386-8494-0B4CA4DD3FBDQ31143905-A70F94A4-85D0-4893-887E-BFECEB003F51Q33302616-A5990B7D-2F7C-4EBD-83D8-DD74DC14525BQ33552301-CC0EB1A0-F738-4347-B91B-9546A84B4E24Q33573874-847B0CE2-800F-46D2-BE18-66A8F682A21BQ33636242-B9E60206-559B-4CB7-91D3-B40426F81C9CQ33697312-F37817A0-4F70-4AEB-ADB6-6A2BB95FA7B4Q33781476-AD8FF928-43FD-4442-B65B-AF2E5D78EF51Q33841893-FB75620E-A277-4ED5-964F-6FDB9E3FA366Q33847160-75D2EF0E-D38C-4B1E-99DD-B99AAE8967EAQ33889353-2CDC57E6-7B97-4EB2-A1A0-BC0A755D8562Q33954437-3B41E084-04D4-453C-A72F-B7A4153C11CFQ34131760-73E84853-D294-49ED-9B86-BABC9CC65ADCQ34344456-2D4852B4-129E-4378-9564-9C06D4CF6502Q34524556-3F25F447-971F-47B0-ACCD-E2D8B037A7AFQ34680962-EAD2875B-8ED3-4162-AA13-B55BA79ACE12Q34764667-1AFD50C6-5A73-402E-8892-CA7AFE7AB3DAQ34982537-6CAC9162-194F-4616-9E8D-B14F290A8064Q34985850-07A0CDC3-1BE8-4628-94AF-D529A7575511
P2860
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Differential actions of antipa ...... cloned human receptor subtypes
@ast
Differential actions of antipa ...... cloned human receptor subtypes
@en
Differential actions of antipa ...... cloned human receptor subtypes
@nl
type
label
Differential actions of antipa ...... cloned human receptor subtypes
@ast
Differential actions of antipa ...... cloned human receptor subtypes
@en
Differential actions of antipa ...... cloned human receptor subtypes
@nl
prefLabel
Differential actions of antipa ...... cloned human receptor subtypes
@ast
Differential actions of antipa ...... cloned human receptor subtypes
@en
Differential actions of antipa ...... cloned human receptor subtypes
@nl
P2093
P3181
P356
P1476
Differential actions of antipa ...... cloned human receptor subtypes
@en
P2093
Didier Cussac
Lisa Maiofiss
Mark J Millan
Valérie Audinot
P304
P3181
P356
10.1124/JPET.102.039867
P407
P577
2002-11-01T00:00:00Z